Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of VIR-2482 in Healthy Adults for Prevention of Influenza A Illness (PENINSULA).
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 03, 2024
Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial.
Journal: Open forum infectious diseases
Published: June 26, 2023
Antibody therapy reverses biological signatures of COVID-19 progression.
Journal: Cell reports. Medicine
Published: February 09, 2022
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.
Journal: The New England journal of medicine
Published: October 27, 2021
After the pandemic: perspectives on the future trajectory of COVID-19.
Journal: Nature
Published: May 12, 2021
Successful Re-treatment of Hepatitis C Virus in Patients Coinfected With HIV Who Relapsed After 12 Weeks of Ledipasvir/Sofosbuvir.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 29, 2016
Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection.
Journal: Hepatology (Baltimore, Md.)
Published: February 21, 2016
On-treatment HCV RNA in patients with varying degrees of fibrosis and cirrhosis in the SOLAR-1 trial.
Journal: Antiviral therapy
Published: January 21, 2016
A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus.
Journal: Hepatology international
Published: January 08, 2016
Last Updated: 09/26/2026